
QT Prolongation
Visualize Pharmacology
Drug-induced QT prolongation
QT prolongation reflects delayed ventricular repolarization and can increase susceptibility to torsades de pointes. Blockade of the hERG potassium channel is an important medication mechanism, but other mechanisms and patient factors also contribute.

Medication mechanisms and exposure
Citalopram is one medication with QT considerations. Its ballicule diagram illustrates pharmacology; the CYP2C19 avatar highlights a metabolic pathway relevant to medication exposure.

Risk depends on the whole clinical picture
Low potassium or magnesium, slow heart rate, structural heart disease, congenital long-QT syndrome and combinations of QT-prolonging medicines can increase risk. Dose, drug interactions and impaired clearance also matter.
ECG and electrolyte assessment may be appropriate before or during higher-risk treatment. A mechanism diagram cannot determine an individual patient’s arrhythmia risk.
Open citalopram in Ballicules.com console
Go to CYP2C19 on ballicules.com